Product Code: ETC9392115 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Africa Shingles Vaccine Market Overview |
3.1 South Africa Country Macro Economic Indicators |
3.2 South Africa Shingles Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 South Africa Shingles Vaccine Market - Industry Life Cycle |
3.4 South Africa Shingles Vaccine Market - Porter's Five Forces |
3.5 South Africa Shingles Vaccine Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 South Africa Shingles Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
4 South Africa Shingles Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about shingles and its complications among the South African population. |
4.2.2 Growing elderly population in South Africa, who are more susceptible to shingles. |
4.2.3 Government initiatives and campaigns promoting vaccination and preventive healthcare. |
4.3 Market Restraints |
4.3.1 High cost associated with shingles vaccination, limiting affordability for some segments of the population. |
4.3.2 Limited access to healthcare facilities, particularly in rural areas, impacting vaccine distribution. |
4.3.3 Concerns regarding the safety and efficacy of shingles vaccines among the public. |
5 South Africa Shingles Vaccine Market Trends |
6 South Africa Shingles Vaccine Market, By Types |
6.1 South Africa Shingles Vaccine Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 South Africa Shingles Vaccine Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 South Africa Shingles Vaccine Market Revenues & Volume, By Shingrix, 2021- 2031F |
6.1.4 South Africa Shingles Vaccine Market Revenues & Volume, By Zostavax, 2021- 2031F |
6.1.5 South Africa Shingles Vaccine Market Revenues & Volume, By SKYZoster, 2021- 2031F |
6.2 South Africa Shingles Vaccine Market, By Vaccine Type |
6.2.1 Overview and Analysis |
6.2.2 South Africa Shingles Vaccine Market Revenues & Volume, By Recombinant Vaccine, 2021- 2031F |
6.2.3 South Africa Shingles Vaccine Market Revenues & Volume, By Live Attenuated Vaccine, 2021- 2031F |
7 South Africa Shingles Vaccine Market Import-Export Trade Statistics |
7.1 South Africa Shingles Vaccine Market Export to Major Countries |
7.2 South Africa Shingles Vaccine Market Imports from Major Countries |
8 South Africa Shingles Vaccine Market Key Performance Indicators |
8.1 Vaccination coverage rate among the elderly population in South Africa. |
8.2 Number of healthcare facilities offering shingles vaccination services. |
8.3 Percentage of population reached through government vaccination campaigns. |
8.4 Rate of reported shingles cases in South Africa. |
8.5 Level of public trust and confidence in shingles vaccines. |
9 South Africa Shingles Vaccine Market - Opportunity Assessment |
9.1 South Africa Shingles Vaccine Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 South Africa Shingles Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
10 South Africa Shingles Vaccine Market - Competitive Landscape |
10.1 South Africa Shingles Vaccine Market Revenue Share, By Companies, 2024 |
10.2 South Africa Shingles Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |